Intercept Presents New Data Demonstrating the Impact of OCA-Bezafibrate Combination Therapy on ALP and Metabolic Outcomes After Six Months of Treatment at Digestive Disease Week® 2024
May 18, 2024 08:00 ET
|
Intercept Pharmaceuticals, Inc.
Results from a Phase 2 study show combination of OCA 5-10mg and bezafibrate 400mg induced the greatest percent change from baseline in ALP at Month 6 OCA and bezafibrate combination therapy has...
BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
May 17, 2024 16:33 ET
|
BriaCell Therapeutics Corp.
PHILADELPHIA and VANCOUVER, British Columbia, May 17, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...
Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day
May 17, 2024 16:05 ET
|
Terns Pharmaceuticals, Inc.
FOSTER CITY, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...
NurExone Welcomes Biopharma Exec Dr. Ram Petter to Drive Strategic Collaborations
May 17, 2024 16:04 ET
|
NurExone Biologic Inc
NurExone Welcomes Biopharma Executive Dr. Ram Petter to Drive Strategic Collaborations
Recludix Pharma Presents Data Demonstrating Oral STAT3 Inhibitors Drive Differentiated Efficacy and Safety in Preclinical Models of Th17 Mediated Skin Inflammation in Oral Plenary Session at SID Annual Meeting
May 17, 2024 15:00 ET
|
Recludix Pharma, Inc.
-- In a preclinical model of psoriasis, the efficacy of oral small molecule REX-7117 was comparable to an anti-IL-17A biologic SAN DIEGO, May 17, 2024 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader...
Hepatitis: The silent killer
May 17, 2024 12:37 ET
|
Missouri Department of Health and Senior Services
May is Hepatitis Awareness Month, the perfect time for individuals to talk to their health care providers about hepatitis vaccinations.
キング・ファイサル・スペシャリスト病院･研究センター (King Faisal Specialist Hospital and Research Centre) がバリューベース・ヘルスケア (VBHC) から2024年テック・インパクト・アワード (2024 Tech Impact Award) を受賞
May 17, 2024 12:06 ET
|
King Faisal Specialist Hospital & Research Centre
サウジアラビア・リヤド発 , May 18, 2024 (GLOBE NEWSWIRE) -- キング・ファイサル・スペシャリスト病院･研究センター (King Faisal Specialist Hospital and Research Centre、KFSHRC) がバリューベース・ヘルスケア・ヨーロッパ (Value-Based Health Care Centre Europe)...
Il King Faisal Specialist Hospital & Research Centre vince il Tech Impact Award 2024 di VBHC
May 17, 2024 12:06 ET
|
King Faisal Specialist Hospital & Research Centre
RIYADH, Arabia Saudita, May 17, 2024 (GLOBE NEWSWIRE) -- Il King Faisal Specialist Hospital & Research Centre (KFSHRC) ha raggiunto un traguardo significativo vincendo l'edizione del 2024 del...
King Faisal Specialist Hospital & Research Centre gewinnt Tech Impact Award 2024 des VBHC
May 17, 2024 12:06 ET
|
King Faisal Specialist Hospital & Research Centre
RIAD, Saudi-Arabien, May 17, 2024 (GLOBE NEWSWIRE) -- Das King Faisal Specialist Hospital & Research Centre (KFSHRC) hat einen bedeutenden Meilenstein erreicht, indem es den 2024 Tech Impact...
Le King Faisal Specialist Hospital & Research Centre lauréat du prix « Tech Impact » VBHC 2024
May 17, 2024 12:06 ET
|
King Faisal Specialist Hospital & Research Centre
RIYAD, Arabie Saoudite, 17 mai 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre, ci-après « KFSH&RC », soit l’hôpital spécialisé et centre de recherche King...